Manashjit Gogoi – författare

This edited book provides a comprehensive exploration of cutting-edge nanomedicine, bringing together leading research on the design and application of nanoparticles and nanomaterials across a wide spectrum of biomedical fields. Covering topics from tissue engineering, drug delivery, and biomedical implants to cancer therapeutics and precision medicine, the volume highlights how nanotechnology is revolutionizing diagnostics, therapies, and the management of complex diseases. Chapters also examine innovative developments in quantum dots, gene therapy, and strategies for tackling neglected tropical diseases, alongside critical assessments of biocompatibility, toxicity, and the regulatory landscape shaping the future of nanomedicine. This book serves as an essential reference for researchers, clinicians, and policymakers interested in emerging trends, challenges, and translational breakthroughs at the intersection of nanoscience and healthcare.

This edited book provides a comprehensive exploration of cutting-edge nanomedicine, bringing together leading research on the design and application of nanoparticles and nanomaterials across a wide spectrum of biomedical fields. Covering topics from tissue engineering, drug delivery, and biomedical implants to cancer therapeutics and precision medicine, the volume highlights how nanotechnology is revolutionizing diagnostics, therapies, and the management of complex diseases. Chapters also examine innovative developments in quantum dots, gene therapy, and strategies for tackling neglected tropical diseases, alongside critical assessments of biocompatibility, toxicity, and the regulatory landscape shaping the future of nanomedicine. This book serves as an essential reference for researchers, clinicians, and policymakers interested in emerging trends, challenges, and translational breakthroughs at the intersection of nanoscience and healthcare.

This edited book provides a comprehensive exploration of cutting-edge nanomedicine, bringing together leading research on the design and application of nanoparticles and nanomaterials across a wide spectrum of biomedical fields. Covering topics from tissue engineering, drug delivery, and biomedical implants to cancer therapeutics and precision medicine, the volume highlights how nanotechnology is revolutionizing diagnostics, therapies, and the management of complex diseases. Chapters also examine innovative developments in quantum dots, gene therapy, and strategies for tackling neglected tropical diseases, alongside critical assessments of biocompatibility, toxicity, and the regulatory landscape shaping the future of nanomedicine. This book serves as an essential reference for researchers, clinicians, and policymakers interested in emerging trends, challenges, and translational breakthroughs at the intersection of nanoscience and healthcare.

This book explores cutting-edge research and applications in the field of nanomedicines for cancer imaging, diagnosis, and therapy. It begins by highlighting the pivotal role of engineered silica-based nanoparticles in the precise delivery of anticancer drugs. The book further delves into the versatile utilization of metallic nanoparticles for hyperthermia and chemotherapy, showcasing their efficacy in combating cancer and reducing treatment-related discomfort. Additionally, it examines the applications of functionalized nanomaterials in the emerging field of cancer stem cell therapy and the use of radioactive nanoparticles for precise cancer diagnosis and therapy. The book also provides a thorough review of the potential of functionalized lipid-based nanoparticles for precision and targeted treatment. It discusses the roles of dendrimer-based nanomaterials, carbon-based nanomedicines, inorganic nanostructured materials, and polymeric nanomaterials in the realms of cancer diagnosis and personalized, targeted cancer therapies. Finally, the book delves into the commercial aspects of nanomedicines, addressing the challenges and future prospects of introducing these groundbreaking technologies to the forefront of cancer care.Key Features:Provides a comprehensive overview of the latest advancements in nanomedicines for cancer diagnosis and therapyEmphasizes the pivotal role of engineered silica-based nanoparticles for precise anticancer drug deliveryExplore use of metallic nanoparticles for hyperthermia and chemotherapyDiscusses radioactive nanoparticles for precise diagnosis and functionalized lipid-based nanoparticles for targeted treatmentAddresses the commercial aspects of nanomedicines, offering insights into the challenges and future prospects of these innovative technologies in the field of cancer careThis book is an invaluable resource for researchers and scientists in the fields of nanomedicine, oncology, and drug delivery systems.

This book summarizes the principles, protocols, and applications of enzyme-based biosensors in healthcare. After providing a brief history and discussing the development of various biosensors used for medical applications, it explores the principles of enzyme-based biosensors and reviews a number of enzyme immobilization techniques. It then addresses the potential of enzyme-based biosensors in the diagnosis of infectious and non-infectious diseases; illustrates the potential of enzyme-based biosensors for non-invasive monitoring of biochemical biomarkers; and assesses the application of paper-based and microfluidic-based nanobiosensors in medical diagnostics. A one-stop resource on recent advances in enzyme-based biosensors in healthcare, this book will appeal to students, researchers and scientists in a range of disciplines, as well as entrepreneurs, and medical/healthcare professionals.

This book summarizes the principles, protocols, and applications of enzyme-based biosensors in healthcare. After providing a brief history and discussing the development of various biosensors used for medical applications, it explores the principles of enzyme-based biosensors and reviews a number of enzyme immobilization techniques. It then addresses the potential of enzyme-based biosensors in the diagnosis of infectious and non-infectious diseases; illustrates the potential of enzyme-based biosensors for non-invasive monitoring of biochemical biomarkers; and assesses the application of paper-based and microfluidic-based nanobiosensors in medical diagnostics. A one-stop resource on recent advances in enzyme-based biosensors in healthcare, this book will appeal to students, researchers and scientists in a range of disciplines, as well as entrepreneurs, and medical/healthcare professionals.

This book examines the role of nanobiosensors in point-of-care applications for personalized healthcare and management. It begins by discussing various biomaterials that are used for the development of biosensors in medical diagnostics, and reviews advances in their fabrication and the miniaturization of biosensor devices for lab-on-chip analysis. In turn, it explores the rapidly evolving applications of nanomaterials in the context of biomaterial diagnostics.The book also explores the immense potential of biosensors in medical diagnostics, where they are increasingly being used to detect a wide range of biomolecules and biomarkers. In closing, it discusses the current challenges and outlines the future role of nanobiosensors in the development of next-generation point-of-care applications.

This book examines the role of nanobiosensors in point-of-care applications for personalized healthcare and management. It begins by discussing various biomaterials that are used for the development of biosensors in medical diagnostics, and reviews advances in their fabrication and the miniaturization of biosensor devices for lab-on-chip analysis. In turn, it explores the rapidly evolving applications of nanomaterials in the context of biomaterial diagnostics.

The book also explores the immense potential of biosensors in medical diagnostics, where they are increasingly being used to detect a wide range of biomolecules and biomarkers. In closing, it discusses the current challenges and outlines the future role of nanobiosensors in the development of next-generation point-of-care applications.